Novartis Aktie
145,48
EUR
+1,10
EUR
+0,76
%
145,28
EUR
-0,22
EUR
-0,15
%
Erwachsen handeln.
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Werbung
Novartis Aktie Analyse
| 07.01.22 | Novartis Neutral | UBS AG | |
| 13.12.21 | Novartis Neutral | Credit Suisse Group | |
| 03.12.21 | Novartis Neutral | UBS AG | |
| 26.11.21 | Novartis Neutral | UBS AG | |
| 05.11.21 | Novartis Neutral | UBS AG | |
| 27.10.21 | Novartis Neutral | Credit Suisse Group | |
| 12.10.21 | Novartis Market-Perform | Bernstein Research | |
| 17.09.21 | Novartis Hold | Deutsche Bank AG | |
|
Werbung
|
|||
| 13.09.21 | Novartis Hold | Deutsche Bank AG | |
| 06.09.21 | Novartis Hold | Kepler Cheuvreux | |
| 22.07.21 | Novartis Hold | Deutsche Bank AG | |
| 22.07.21 | Novartis Neutral | Credit Suisse Group | |
| 21.07.21 | Novartis Market-Perform | Bernstein Research | |
| 21.07.21 | Novartis Market-Perform | Bernstein Research | |
| 24.06.21 | Novartis Hold | Kepler Cheuvreux | |
| 07.06.21 | Novartis Neutral | Credit Suisse Group | |
| 28.04.21 | Novartis Neutral | Credit Suisse Group | |
| 27.04.21 | Novartis market-perform | Bernstein Research | |
| 23.03.21 | Novartis market-perform | Bernstein Research | |
| 22.03.21 | Novartis market-perform | Bernstein Research | |
| 27.01.21 | Novartis Neutral | Credit Suisse Group | |
| 26.01.21 | Novartis Hold | Kepler Cheuvreux | |
| 25.01.21 | Novartis Neutral | Oddo BHF | |
| 20.01.21 | Novartis Neutral | Credit Suisse Group | |
| 28.10.20 | Novartis Neutral | Credit Suisse Group | |
| 21.08.20 | Novartis Neutral | UBS AG | |
| 28.07.20 | Novartis neutral | Morgan Stanley | |
| 22.07.20 | Novartis Hold | HSBC | |
| 22.07.20 | Novartis Neutral | Credit Suisse Group | |
| 21.07.20 | Novartis Equal-Weight | Morgan Stanley | |
| 21.07.20 | Novartis Hold | Kepler Cheuvreux | |
| 21.07.20 | Novartis Neutral | UBS AG | |
| 25.06.20 | Novartis Neutral | UBS AG | |
| 21.05.20 | Novartis Neutral | UBS AG | |
| 11.05.20 | Novartis Neutral | UBS AG | |
| 30.04.20 | Novartis Hold | HSBC | |
| 29.04.20 | Novartis Neutral | Credit Suisse Group | |
| 28.04.20 | Novartis Neutral | UBS AG | |
| 06.04.20 | Novartis Hold | Deutsche Bank AG | |
| 20.03.20 | Novartis Hold | Deutsche Bank AG | |
| 11.03.20 | Novartis Equal-Weight | Morgan Stanley | |
| 26.02.20 | Novartis Hold | Deutsche Bank AG | |
| 25.02.20 | Novartis Neutral | UBS AG | |
| 31.01.20 | Novartis Hold | Deutsche Bank AG | |
| 30.01.20 | Novartis Neutral | Credit Suisse Group | |
| 29.01.20 | Novartis Neutral | UBS AG | |
| 29.01.20 | Novartis Hold | Kepler Cheuvreux | |
| 16.01.20 | Novartis Neutral | Credit Suisse Group | |
| 09.01.20 | Novartis Hold | Deutsche Bank AG | |
| 12.12.19 | Novartis Hold | Deutsche Bank AG | |
Werbung
Werbung